Common use of Authorization to Use and Disclose Health Information Clause in Contracts

Authorization to Use and Disclose Health Information. Institution shall provide an appropriate privacy statement to each Trial, complying with Applicable Law, which will enable Institution and Principal Investigator to provide Sponsor and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. If such an authorization is separate from the ICF, Institution will only use the authorization that is approved by Sponsor, IEC and/or RA (if applicable).

Authorization to Use and Disclose Health Information. Institution shall provide an appropriate privacy statement notice to each TrialStudy Subject and obtain a written privacy authorization from each Study Subject, complying with Applicable Law, which will enable Institution and Principal Investigator to provide Sponsor and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. If such an authorization is separate from the ICF, Institution will only use the authorization that is approved by Sponsor, IEC and/or RA (if applicable).

Authorization to Use and Disclose Health Information. Institution Provider shall provide an appropriate privacy statement notice to each TrialTrial Subject and obtain a written privacy authorization from each Trial Subject, complying with Applicable Law, which will enable Institution Provider and Principal Investigator to provide Sponsor Sponsor, CRO and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. If such an authorization is separate from the ICF, Institution Provider will only use the authorization that is approved by Sponsor, IEC and/or RA (if applicable).

Authorization to Use and Disclose Health Information. Institution shall provide an appropriate privacy statement notice to each TrialTrial Subject and obtain a written privacy authorization from each Trial Subject, complying with Applicable Law, which will enable Institution and Principal Investigator to provide Sponsor and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. If such an authorization is separate from the ICF, Institution will only use the authorization that is approved by SponsorSponsor or its designee, IEC and/or RA (if applicable).

Authorization to Use and Disclose Health Information. Institution shall provide an appropriate appropiate privacy statement notice to each TrialTrial Subject and obtain a written privacy authorization from each Trial Subject, complying with Applicable Law, which will enable Institution and Principal Investigator to provide Sponsor and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. If such an authorization is separate from the informed consent form (“ICF”), Institution will only use the authorization that is approved by Sponsor, IEC and/or RA (if applicable).